Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelomonocytic, Chronic

Explore clinical trials studying Leukemia, Myelomonocytic, Chronic. Study availability and eligibility vary by location and protocol.

20 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelomonocytic, Chronic trial results

Completed

Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

NCT03268954

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +13 more
Locations
  • Southern Cancer Center - USOR Daphne, Alabama, United States
  • Southern Cancer Center - USOR Mobile, Alabama, United States
  • Southern Cancer Center - USOR Mobile, Alabama, United States
  • Southern Cancer Center- USOR Mobile, Alabama, United States
View all 242 locations
View Trial Details
Completed

A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

NCT03814005

Conditions
Bone Marrow Diseases, Chronic Disease, Digestive System Diseases, +22 more
Locations
  • Icahn School of Medicine at Mount Sinai New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • ICO lHospitalet Hospital Duran i Reynals LHospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Vall d'Hebron - PPDS Barcelona, Spain
View Trial Details
Completed

Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs

NCT02907359

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • City of Hope Duarte, California, United States
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • Cancer Specialists of North Florida Fleming Island, Florida, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
View all 112 locations
View Trial Details
Completed

Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia

NCT02807272

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +10 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)

NCT02610777

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Greenville Health System Little Rock, Arkansas, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Compassionate Cancer Care Medical Group Incorporated Riverside, California, United States
View all 59 locations
View Trial Details

Related conditions